Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Phase II Resumes, Upbeat NR

<< Previous

Bullboard Posts

Next >>

Comment by goldn1on Aug 18, 2020 12:45pm

236 Views

Post# 31423411

RE:RE:RE:RE:RE:RE:RE:RE:RE:Phase II Resumes, Upbeat NR

Hempy:

You recently made a post about TLT creating generational wealth in the future. I would love to see that and bought into this company initially thinking they were on to something, but there are other treatments which are advancing and TLT has a hard time doing things in a timely manner. The results of the first 12 patients was a big disappointment, imo as if treated propertly, it could have put TLT on the map. I am surprised that scans are not done prior to enrollment showing other cancers as these patients have been bcg unresponsive and I am sure have had a lot of treatment/scans/re-treatment, etc. Regardless, it is the iniability to fill the bladder properly is something that shouldn't happen in a PH2...

I would love to see this technology work for the patients and investors, but @ 17 cents, why do you feel the rest of the world outside of stockhouse has no interest or excitement. not mackie, not anyone that may have went to the investor conference, it seems most big shareholders are dumping any chance they can get and don't see a bright future for TLT.

Thanks,

G1

<< Previous

Bullboard Posts

Next >>

Silver Range Resources: A hidden gem in the mining industry